Abstract
Familial idiopathic basal ganglia calcification (IBGC) is a rare neurodegenerative syndrome with an autosomal dominant pattern of inheritance which is characterized by deposition of calcium in the basal ganglia and other brain regions. Linkage studies demonstrated its genetic heterogeneity; however, the responsible genes are unknown. Recently, a heterozygous variation (C>G, P521A) at exon 20 of the human cutaneous T cell lymphoma-associated antigen 5 (CTAGE5) gene was found in all patients of the affected large American family linked to IBGC1 (14q11.2-21.3). However, no carrier was detected in the two affected Brazilian families. This study was performed to investigate whether the CTAGE5 P521A variation is associated with the IBGC in an affected Iranian family. Genotyping of the CTAGE5 P521A variation was determined using PCR-RFLP. Totally, 22 members of an affected Iranian family as well as 100 normal people as control group were screened. All the samples including 22 members of the affected family as well as all control people had normal CC genotype and no GC carrier was found. Our result is similar to a Brazilian study but contrary to an American report, strengthening genetic heterogeneity of this syndrome. It seems that additional studies are necessary to confirm the pathogenicity of this rare mutation.
This is a preview of subscription content, log in via an institution to check access.
References
Brodaty H, Mitchell P, Luscombe G et al (2002) Familial idiopathic basal ganglia calcification (Fahr’s disease) without neurological, cognitive and psychiatric symptoms is not linked to the IBGC1 locus on chromosome 14q. Hum Genet 110:8–14
Comtesse N, Reus K, Meese E (2001) The MGEA6 multigene family has an active locus on14q and at least nine pseudogenes no different chromosomes. Genomics 75:1–6
Comtesse N, Niedermayer I, Glass B et al (2002) MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies. Oncogene 21:239–247
Dai X, Gao Y, Xu Z et al (2010) Identification of a novel genetic locus on chromosome 8p21.1-q11.23 for idiopathic basal ganglia calcification. Am J Med Genet B Neuropsychiatr Genet 153B:1305–1310
Ellie E, Julien J, Ferrer X (1989) Familial idiopathic striopallidodentate calcifications. Neurology 39:381–385
Freudenberg-Hua Y, Freudenberg J, Kluck N, Cichon S, Propping P, Nothen MM (2003) Single nucleotide variation analysis in 65 candidate genes for CNS disorders in a representative sample of the European population. Genome Res 13:2271–2276
Geschwind DH, Loginov M, Stern JM (1999) Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr’s disease). Am J Hum Genet 65:764–772
König P, Haller R (1985) Results of a study of a family with aggregated occurrence of bilateral symmetrical basal ganglia calcinosis. Eur Arch Psychiatry Neurol Sci 234:325–334
Kostić VS, Lukić-Ječmenica M, Novaković I et al (2011) Exclusion of linkage to chromosomes 14q, 2q37 and 8p21.1-q11.23 in a Serbian family with idiopathic basal ganglia calcification. J Neurol 258:1637–1642
Lemos RR, Oliveira DF, Zatz M, Oliveira JR (2011) Population and computational analysis of the MGEA6 P521A variation as a risk factor for familial idiopathic basal ganglia calcification (Fahr’s disease). J Mol Neurosci 43:333–336
Manyam BV (2005) What is and what is not ‘Fahr’s disease’. Parkinsonism Relat Disord 11:73–80
Manyam BV, Bhatt MH, Moore WD, Devleschoward AB, Anderson DR, Calne DB (1992) Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies. Ann Neurol 31:379–384
Oliveira JR, Spiteri E, Sobrido MJ et al (2004) Genetic heterogeneity in familial idiopathic basal ganglia calcification (“Fahr’s disease”). Neurology 63:2165–2167
Oliveira JR, Sobrido MJ, Spiteri E et al (2007) Analysis of candidate genes at the IBGC1 locus associated with idiopathic basal ganglia calcification (“Fahr’s disease”). J Mol Neurosci 33:151–154
Volpato CB, De Grandi A, Buffone E et al (2008) Exclusion of linkage to chromosome 14q in a large South Tyrolean family with idiopathic basal ganglia calcification (IBGC). Am J Med Genet B Neuropsychiatr Genet 147B:1319–1322
Volpato CB, De Grandi A, Buffone E et al (2009) 2q37 as a susceptibility locus for idiopathic basal ganglia calcification (IBGC) in a large South Tyrolean family. J Mol Neurosci 39:346–353
Wang C, Li Y, Shi L et al (2012) Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet 44:254–256
Acknowledgments
We would like to thank all the family members for their participation in this study. The authors thank Mrs. Zhamak Pahlevanzadeh for the DNA extraction of the samples.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saliminejad, K., Ashtari, F., Kamali, K. et al. Analysis of the CTAGE5 P521A Variation with the Risk of Familial Idiopathic Basal Ganglia Calcification in an Iranian Population. J Mol Neurosci 49, 614–617 (2013). https://doi.org/10.1007/s12031-012-9898-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-012-9898-y